輸血診断の世界市場レポート 2025年

輸血診断の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で64億3,000万米ドルに成長します。予測期間の成長は、精密医療への需要の高まり、輸血インフラへの投資の増加、分子輸血への需要の高まり、新興感染症、血液の安全性への懸念に起因しています。予測期間の主な動向には、診断の進歩、ポイントオブケア検査、自動化とロボット化、核酸検査（NAT）、デジタル統合、病原体パネルの拡大、高度な検査技術などがあります。

輸血診断の需要は、年間手術件数の増加により増加傾向にあります。これらの診断は、患者に輸血する前に献血された血液をスクリーニングし、潜在的な感染症を予防する上で極めて重要です。毎年3億1,000万件の手術が行われていると推定され、輸血診断の必要性はこれらの手術と連動して高まっています。

血液関連疾患は輸血診断市場の拡大に大きく貢献しています。貧血、白血病、血液凝固障害などの疾患は、早期発見と安全な管理のために正確な診断が必要です。これらの疾患の流行は明らかで、2023年1月の統計によると、白血病の新規患者数は約5万9,610人、死亡者数は約2万3,710人であり、急性骨髄性白血病（AML）の新規患者数は約2万380人でした。急性骨髄性白血病（AML）の新規患者数は約2万380人です。このような有病率の高さから、患者の最適な治療を保証するための診断法の改善が求められています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の輸血診断市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の輸血診断市場：成長率分析
• 世界の輸血診断市場の実績：規模と成長、2019～2024年
• 世界の輸血診断市場の予測：規模と成長、2024～2029年、2034年
• 世界の輸血診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の輸血診断市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 機器・キット
• 試薬
• その他
• 世界の輸血診断市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ウェスタンブロット
• ELISA
• 核酸増幅
• 蛍光アッセイ
• 迅速検査
• 世界の輸血診断市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液型検査
• 病気のスクリーニング
• 世界の輸血診断市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 診断検査室
• 血液バンク
• 血漿分画会社
• 世界の輸血診断市場：機器・キットのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血液型検査機器
• 交差適合キット
• 血液検査機器
• 自動血液処理システム
• 世界の輸血診断市場：試薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗血清
• 制御ソリューション
• 血液型判定試薬
• 酵素およびその他の試薬
• 世界の輸血診断市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ソフトウェアソリューション
• 消耗品
• トレーニングおよびサポートサービス

第7章 地域別・国別分析

• 世界の輸血診断市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の輸血診断市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 輸血診断市場：競合情勢
• 輸血診断市場：企業プロファイル
  • BAG Health Care GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Immucor Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ortho Clinical Diagnostics
• DiaSorin S.p.A
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Beckman Coulter Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd.
• Quotient Limited
• Hologic Inc.
• Roche Diagnostics
• bioMerieux
• Diagast SAS
• Fujirebio
• Biokit S.A.
• QuidelOrtho Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 輸血診断市場2029：新たな機会を提供する国
• 輸血診断市場2029：新たな機会を提供するセグメント
• 輸血診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Blood transfusion diagnostics play a crucial role in conducting tests before the transfer of blood between donors and recipients, encompassing assessments like blood grouping and disease screening.

These diagnostics are primarily categorized into instruments and kits, along with reagents and other ancillary tools. Blood transfusion diagnostic kits are instrumental in collecting and safely transfusing blood, utilizing technologies like western blot, ELISA, nucleic acid amplification, fluorescence assays, and rapid testing. These technologies are employed across diverse applications, specifically in blood grouping and disease screening procedures. End-users of blood transfusion diagnostics span various sectors, including hospitals, diagnostic laboratories, blood banks, and companies engaged in plasma fractionation. These entities rely on these diagnostic tools to ensure the safe and accurate transfer of blood components between donors and recipients.

The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood transfusion diagnostics market size has grown rapidly in recent years. It will grow from $4.42 billion in 2024 to $4.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing blood transfusions, emerging pathogens, aging population, increasing demand for rapid blood transfusion diagnostics, rising prevalence of chronic diseases, increased blood demand.

The blood transfusion diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising demand for precision medicine, growing investment in blood transfusion infrastructure, growing demand for molecular blood transfusions, emerging infectious diseases, blood safety concerns. Major trends in the forecast period include advancements in diagnostics, point-of-care testing, automation and robotics, nucleic acid testing (NAT), digital integration, expanded pathogen panels, advanced testing technologies.

The demand for blood transfusion diagnostics is on the rise, fueled by the increasing number of surgeries performed annually. These diagnostics are crucial in screening donated blood before transfusion to patients, preventing potential infectious diseases. With an estimated 310 million surgeries conducted each year, the necessity for blood transfusion diagnostics is growing in tandem with these procedures.

Blood-related diseases are contributing significantly to the expansion of the blood transfusion diagnostics market. Conditions like anemias, leukemia, and clotting disorders necessitate precise diagnostics for early detection and safe management. The prevalence of these diseases is evident, with statistics from January 2023 showing approximately 59,610 new cases and 23,710 deaths from leukemia, while acute myeloid leukemia (AML) accounted for around 20,380 new cases. This prevalence drives the need for improved diagnostics to ensure optimal patient care.

The inclination toward nucleic acid amplification testing (NAT) for blood safety and efficiency is growing due to its accuracy in detecting pathogens like bacteria and viruses. This testing method, detecting specific nucleic acids of pathogens in blood, tissue, or urine, offers high sensitivity and early identification of infectious diseases. XCRP Diagnostic Inc. and Luminex Corporations' agreement for the Xtreme Chain Reaction Nucleic Acid Amplification Technology exemplifies the industry's focus on advancing diagnostic capabilities through strategic partnerships.

Leading companies in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion methods, to enhance the accuracy of blood typing, improve patient safety, minimize the risk of transfusion-transmitted infections, and optimize the overall transfusion process. Innovations in transfusion technology encompass advancements in the methods, devices, and processes utilized in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a biotechnology company based in France, introduced Omnys, a significant innovation in blood grouping and testing. This cutting-edge diagnostic platform is designed to deliver rapid and precise blood typing, compatibility testing, and pathogen detection. It utilizes advanced biomarker identification and automation to streamline the transfusion process, ensuring that blood products are accurately matched to patients for safe transfusions.

Major companies operating in the blood transfusion diagnostics market include BAG Health Care GmbH, Grifols S.A., Bio-Rad LaboratoriesInc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Novartis AG, F. Hoffmann-La Roche Ltd., bioMerieux, Diagast SAS, Fujirebio, Biokit S.A., QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sekisui Diagnostics, Sysmex Corporation, Werfen S.A.

North America was the largest region in the blood transfusion diagnostics market in 2024. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Transfusion Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood transfusion diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood transfusion diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood transfusion diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Instruments and Kits; Reagents; Other Types
• 2) By Technology: Western Blot; ELISA; Nucleic Acid Amplification; Fluorescence assay; Rapid Test
• 3) By Application: Blood Grouping; Disease Screening
• 4) By End User: Hospitals; Diagnostic Laboratories; Blood Banks; Plasma Fractionation Companies
• Subsegments:
• 1) By Instruments and Kits: Blood Typing Instruments; Cross-Matching Kits; Blood Screening Instruments; Automated Blood Processing Systems
• 2) By Reagents: Antisera; Control Solutions; Blood Grouping Reagents; Enzymes and Other Reagents
• 3) By Other Types: Software Solutions; Consumables; Training And Support Services
• Companies Mentioned: BAG Health Care GmbH; Grifols S.A.; Bio-Rad LaboratoriesInc.; Abbott Laboratories; Immucor Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Transfusion Diagnostics Market Characteristics

3. Blood Transfusion Diagnostics Market Trends And Strategies

4. Blood Transfusion Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Blood Transfusion Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Transfusion Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Transfusion Diagnostics Market Growth Rate Analysis
• 5.4. Global Blood Transfusion Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Transfusion Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Transfusion Diagnostics Total Addressable Market (TAM)

6. Blood Transfusion Diagnostics Market Segmentation

• 6.1. Global Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments and Kits
• Reagents
• Other Types
• 6.2. Global Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Western Blot
• ELISA
• Nucleic Acid Amplification
• Fluorescence assay
• Rapid Test
• 6.3. Global Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Grouping
• Disease Screening
• 6.4. Global Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Plasma Fractionation Companies
• 6.5. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Instruments and Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Typing Instruments
• Cross-Matching Kits
• Blood Screening Instruments
• Automated Blood Processing Systems
• 6.6. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antisera
• Control Solutions
• Blood Grouping Reagents
• Enzymes and Other Reagents
• 6.7. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Solutions
• Consumables
• Training And Support Services

7. Blood Transfusion Diagnostics Market Regional And Country Analysis

• 7.1. Global Blood Transfusion Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Transfusion Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Transfusion Diagnostics Market

• 8.1. Asia-Pacific Blood Transfusion Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Transfusion Diagnostics Market

• 9.1. China Blood Transfusion Diagnostics Market Overview
• 9.2. China Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Transfusion Diagnostics Market

• 10.1. India Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Transfusion Diagnostics Market

• 11.1. Japan Blood Transfusion Diagnostics Market Overview
• 11.2. Japan Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Transfusion Diagnostics Market

• 12.1. Australia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Transfusion Diagnostics Market

• 13.1. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Transfusion Diagnostics Market

• 14.1. South Korea Blood Transfusion Diagnostics Market Overview
• 14.2. South Korea Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Transfusion Diagnostics Market

• 15.1. Western Europe Blood Transfusion Diagnostics Market Overview
• 15.2. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Transfusion Diagnostics Market

• 16.1. UK Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Transfusion Diagnostics Market

• 17.1. Germany Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Transfusion Diagnostics Market

• 18.1. France Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Transfusion Diagnostics Market

• 19.1. Italy Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Transfusion Diagnostics Market

• 20.1. Spain Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Transfusion Diagnostics Market

• 21.1. Eastern Europe Blood Transfusion Diagnostics Market Overview
• 21.2. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Transfusion Diagnostics Market

• 22.1. Russia Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Transfusion Diagnostics Market

• 23.1. North America Blood Transfusion Diagnostics Market Overview
• 23.2. North America Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Transfusion Diagnostics Market

• 24.1. USA Blood Transfusion Diagnostics Market Overview
• 24.2. USA Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Transfusion Diagnostics Market

• 25.1. Canada Blood Transfusion Diagnostics Market Overview
• 25.2. Canada Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Transfusion Diagnostics Market

• 26.1. South America Blood Transfusion Diagnostics Market Overview
• 26.2. South America Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Transfusion Diagnostics Market

• 27.1. Brazil Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Transfusion Diagnostics Market

• 28.1. Middle East Blood Transfusion Diagnostics Market Overview
• 28.2. Middle East Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Transfusion Diagnostics Market

• 29.1. Africa Blood Transfusion Diagnostics Market Overview
• 29.2. Africa Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Transfusion Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Blood Transfusion Diagnostics Market Competitive Landscape
• 30.2. Blood Transfusion Diagnostics Market Company Profiles
  • 30.2.1. BAG Health Care GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Immucor Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Blood Transfusion Diagnostics Market Other Major And Innovative Companies

• 31.1. Ortho Clinical Diagnostics
• 31.2. DiaSorin S.p.A
• 31.3. Siemens Healthineers
• 31.4. Thermo Fisher Scientific Inc.
• 31.5. Beckman Coulter Inc.
• 31.6. Novartis AG
• 31.7. F. Hoffmann-La Roche Ltd.
• 31.8. Quotient Limited
• 31.9. Hologic Inc.
• 31.10. Roche Diagnostics
• 31.11. bioMerieux
• 31.12. Diagast SAS
• 31.13. Fujirebio
• 31.14. Biokit S.A.
• 31.15. QuidelOrtho Corporation

32. Global Blood Transfusion Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Transfusion Diagnostics Market

34. Recent Developments In The Blood Transfusion Diagnostics Market

35. Blood Transfusion Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Blood Transfusion Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Transfusion Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Transfusion Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer